Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Artemisinin-resistant Malaria in Cambodia

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
National Institutes of Health Clinical Center (CC) ( National Institute of Allergy and Infectious Diseases (NIAID) )
ClinicalTrials.gov Identifier:
NCT01736319
First received: November 27, 2012
Last updated: August 6, 2016
Last verified: April 2016